12-4649139-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000266544.10(NDUFA9):āc.13G>Cā(p.Ala5Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00196 in 1,604,258 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A5V) has been classified as Likely benign.
Frequency
Consequence
ENST00000266544.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFA9 | NM_005002.5 | c.13G>C | p.Ala5Pro | missense_variant | 1/11 | ENST00000266544.10 | NP_004993.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFA9 | ENST00000266544.10 | c.13G>C | p.Ala5Pro | missense_variant | 1/11 | 1 | NM_005002.5 | ENSP00000266544 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1578AN: 152230Hom.: 30 Cov.: 33
GnomAD3 exomes AF: 0.00227 AC: 524AN: 230680Hom.: 12 AF XY: 0.00170 AC XY: 212AN XY: 124478
GnomAD4 exome AF: 0.00107 AC: 1555AN: 1451910Hom.: 35 Cov.: 31 AF XY: 0.000917 AC XY: 661AN XY: 721032
GnomAD4 genome AF: 0.0104 AC: 1583AN: 152348Hom.: 30 Cov.: 33 AF XY: 0.0103 AC XY: 764AN XY: 74502
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 04, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at